Navigation Links
Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes New Order Dismissing Endo Entities as Defendants in Federal Vaginal Mesh Litigations
Date:4/14/2013

New York, New York (PRWEB) April 14, 2013

Thousands of transvaginal mesh lawsuits continue to proceed in multidistrict litigations underway in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. According to a joint Pretrial Order dated April 3rd, Endo Health Solutions, Inc., Endo Pharmaceuticals, Inc., and American Medical Systems Holdings, Inc. (Endo Entities) have been dismissed as Defendants, per an agreement between the Endo Entities, Defendant American Medical Systems, Inc., and Plaintiffs’ attorneys. The Order applies to all of the vaginal mesh lawsuits filed in the Southern District of West Virginia, including those pending in In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2325”); In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2326); In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2187”); and In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation (“ MDL No. 2327”). Bernstein Liebhard LLP partner, Jeffrey S. Grand, serves on the Plaintiffs’ Steering Committee in all four of these proceedings.

“We are pleased to see these litigations moving forward, as we continue to hear from women who have allegedly suffered horrific transvaginal mesh complications following surgery to treat pelvic organ prolapse and stress urinary incontinence,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently representing hundreds of women in vaginal mesh lawsuits who suffered mesh erosion, pain, scarring, infection and other serious injuries, allegedly due to products marketed by American Medical Systems, Inc., C.R. Bard, Inc., Ethicon, Inc. and Boston Scientific Corp.

Vaginal Mesh Complications
The litigation surrounding vaginal mesh has been growing since 2011, when the U.S. Food & Drug Administration (FDA) warned that there had been a five-fold increase in reports of serious transvaginal mesh complications, including mesh erosion through vaginal tissue, infection, pain, urinary problems, and recurrence of prolapse and/or incontinence. The FDA also modified its previous position on the frequency of such complications, stating in the alert that vaginal mesh injuries associated with pelvic organ prolapse repair were not rare. In January 2012, the agency ordered the manufacturers of vaginal mesh devices used in prolapse repair to conduct post-market safety studies as part of its review.

In addition to the vaginal mesh lawsuits pending in the federal multidistrict litigations, thousands of additional claims involving Ethicon and C.R. Bard products are also pending in two consolidated proceedings underway in Atlantic County Superior Court, New Jersey. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10, and In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10). Bernstein Liebhard LLP partner, Jeffrey Grand is serving as Co-Liaison Counsel in both of these litigations. Earlier this month, the nation’s first trial involving an Ethicon mesh product concluded in New Jersey state court, with the jury awarding more than $11 million in compensatory and punitive damages to the Plaintiff. Mr. Grand also served on the Plaintiff’s trial team. (Gross v. Gynecare Inc., Atl-L-6966-10, Superior Court of Atlantic County, New Jersey (Atlantic City))

Victims of alleged vaginal mesh complications may be entitled to compensation for their medical bills, pain and suffering, and other injuries. A wealth of information regarding transvaginal mesh lawsuits can be found at Bernstein Liebhard's website. To learn more, please call 1-877-779-1414.

*fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/default.htm

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.mesh-lawyers.net/

Read the full story at http://www.prweb.com/releases/transvaginal-mesh-lawsuit/vaginal-mesh-complication/prweb10630431.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. US Drug Watchdog Now Urges Transvaginal Mesh Failure Victims With A Failed Revision Surgery to Call Them for the Names of the Best Possible Women Attorneys
2. Johnson & Johnson Ethicon Transvaginal Mesh Lawsuits Update: Resource4thePeople Reports Judge Schedules More Trials for This Summer
3. PBS Special Shines Light on Issues Involving Transvaginal Mesh Implants
4. TransVaginal Mesh Lawsuit Filed on Behalf of a Georgia Woman Seriously Injured Allegedly Due to Defective TransVaginal Mesh Implants, Reports Wright & Schulte
5. Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Joint Status Conference in Federal Litigations
6. Transvaginal Mesh Lawyer Applauds PBS Program Questioning FDA’s Approval of Pelvic Mesh Products
7. Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conferences in Federal Transvaginal Mesh Litigations
8. Vaginal Mesh Side Effect Sufferer Wins $3.35 Million Lawsuit; Transvaginal Mesh Attorney Jeff Nadrich Responds
9. US Drug Watchdog Now Urges Trial Law Firms To Join Them In A Effort To Help The Most Severely Injured Victims Of A Transvaginal Mesh Failure-With A Local Approach
10. US Drug Watchdog Now Urges Personal Injury Law Firms To Help Them Help Injured Individuals Of A Transvaginal Mesh Failure With A State Specific Approach-The Worst Victims
11. US Drug Watchdog Now Urges Top Personal Injury Trial Lawyers To Join Their State Specific Effort To Help Victims Of A Severe Transvaginal Mesh Failure To Get Compensation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Public relations pros work ... a variety of business channels. , While many results are clear, much of PR ... program. , When it comes to measurement, firms should always take an all-inclusive ...
(Date:3/28/2017)... ... 2017 , ... Oily skin is a common and unwelcomed occurrence in people of all ages, ... to offer to the discussion of dealing with excess skin oil. “Oily skin is a ... remedies that can help remove the oily shine while keeping the skin fresh and clean,” ...
(Date:3/28/2017)... ... ... and fungi are probably not the first ingredients that come to mind when thinking about ... your diet can actually improve health outcomes. And the good news is they may be ... new peer-reviewed paper led by Maria Marco, Ph.D. , University of California, ...
(Date:3/27/2017)... Ohio (PRWEB) , ... March 27, 2017 , ... New ... OH to replace their missing teeth can now have them placed by Dr. Manju ... the latest i-CAT® Cone Beam technology to increase the accuracy of each dental implant ...
(Date:3/27/2017)... TX (PRWEB) , ... March 27, 2017 , ... A ... Edward Buckingham MD, and his colleague, Sudeep Roy, MD, was recently published in ... Bipolar Electrocautery Efficacy in Rhytidectomy” details Drs. Buckingham and Roy’s study on the use ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 2017  BERG, a biopharmaceutical company uncovering ... approach, today announced that the company,s Interrogative ... new data using a cold-induced model to ... Joslin Diabetes Center led the investigation with ... analysis of samples.  The findings were published ...
(Date:3/27/2017)... and BOSTON , ... a leading global pharmaceutical company and Paratek Pharmaceuticals, ... the development and commercialization of innovative therapies based ... 3 trials of sarecycline for the treatment of ... primary efficacy endpoints. Sarecycline is a once-daily, oral, ...
(Date:3/27/2017)...  PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical company ... in children, today reported financial results for the ... 2016 and provided an update on its corporate ... progress during the fourth quarter of 2016 through ... safety study, and with our lead development candidate, ...
Breaking Medicine Technology: